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(propensity scoring, standard and conditional logistic regression,
and Cox proportional hazards function). Control variables
included: demographics (age, gender, race, and region), general
health comorbidities (hypertension and dyslipidemia), mental
health comorbidities (bipolar disorder, depression, post-
traumatic stress disorder, schizophrenia, and substance abuse),
antipsychotic drug utilization patterns (monotherapy, switching,
and combination therapy), treatment duration, medication re-
exposure, and treatment initiation year. Claims databases from
the Veterans Administration North Texas Health Care System
and the South Texas Veterans Health Care System (1995–2004)
were used. RESULTS: Of the eligible patients (N = 8949), regard-
less of variations in methodologies of the seven models, there
were no signiﬁcant differences in diabetes risk among patients
who were: 1) initiated on the second generation antipsychotics
(SGAs) compared to those on the ﬁrst generation antipsychotics
(FGAs); 2) initiated on olanzapine compared to those on risperi-
done; and 3) exposed to olanzapine or quetiapine compared to
those exposed to FGAs. Inconsistent results among the models
were observed when comparisons were made between: 1)
patients initiated on quetiapine (increased risk vs. no difference)
compared to those on risperidone, and 2) patients exposed to
risperidone (decreased risk vs. no difference) compared to those
exposed to FGAs. Differences occurred among the following.
METHODS: ITT retrospective cohort and ITT case-control; and
AT retrospective cohort and AT case-control. CONCLUSIONS:
With respect to antipsychotic utilization, results of the various
models using different methodologies were largely consistent.
Advantages and disadvantages of the seven models will be 
presented.
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OBJECTIVE: To examine whether the relationship between
antipsychotic utilization and treatment-emergent diabetes among
patients newly initiated on therapy varied, when propensity
scoring was (Model I) and was not (Model II) used. METHODS:
Claims databases from the Veterans Administration North Texas
Health Care System and the South Texas Veterans Health Care
System (1995–2004) were used. Both Models I and II utilized a
retrospective cohort design and an intent-to-treat method to
assign treatment exposure. Covariates included demographics
(age, gender, race, and region), general health comorbidities
(hypertension and dyslipidemia), mental health comorbidities
(bipolar disorder, depression, post-traumatic stress disorder,
schizophrenia, and substance abuse), antipsychotic drug utiliza-
tion patterns (monotherapy, switching and combination
therapy), treatment duration, medication re-exposure, and treat-
ment initiation year. Logistic regression was used to analyze data.
RESULTS: Eligible patients (N = 8949) had a 6.0% annual dia-
betes incidence rate. No signiﬁcant difference was found in dia-
betes risk between patients treated with the ﬁrst generation
antipsychotics (FGAs) and the generation antipsychotics (SGAs).
Findings were consistent among most covariates. In both models,
when compared to monotherapy, antipsychotic combination
therapy increased diabetes risk, while switching did not. Antipsy-
chotic re-exposure, early treatment initiation years, and a shorter
treatment duration were associated with an increased diabetes
risk. Results varied with the following two variables: nonwhites
were associated with an increased risk in Model I, while there
was no association in Model II; depression was associated with
an increased risk in Model II, while there was no association in
Model I. All other variables were not signiﬁcant and were con-
sistent between the two models. CONCLUSIONS: SGAs were
not associated with an increased diabetes risk when compared
to FGAs. Including propensity scoring in a retrospective cohort
design may alter the results of some covariates; however, it did
not change the results regarding the class of antipsychotics uti-
lized and risk of diabetes mellitus.
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OBJECTIVES: The objective is to examine the performance of
a variety of ﬁlters used in digital signal processing and evaluate
the ﬁlter coefﬁcients as potential indices of glycemic control.
Digital signal processing has played an extensive role in sepa-
rating signal from noise in biological signals for decades. Cas-
caded adaptive ﬁlters, high pass ﬁlters, Kalman ﬁlters as well as
discrete Fourier transforms have been used to produce clean
signals and obtain the frequency spectrum for ECG signals. With
the rapid advances in Continuous Glucose Monitoring (CGM)
sensors, a nearly continuous stream of glucose levels is made
available with wavelike postprandial excursions. Extraction of
key information beyond descriptive statistics from the mass of
glucose data has been illusive. This is no clean classiﬁcation as
in the case of cardiac arrhythmias. Little prior work in the
medical literature exists except a Kalman ﬁlter simulation using
a sinusoidal function to represent a postprandial excursion
(Palerm, 2005), and a brief note by Knobbe (2005) discussing
Kalman ﬁlters in CGM. METHODS: The mathematical form of
each ﬁlter is presented along with identiﬁcation of associated for-
mulas for each of their ﬁlter coefﬁcients, a table of characteris-
tic ﬁlter coefﬁcients, coefﬁcient ranges, stability and evidence of
substantive interpretability. Archetype postprandial excursions
are represented by truncated Taylor series. RESULTS: Charac-
teristics compared include: stability of ﬁlter coefﬁcient under
trivial curve variation representing the post-prandial excursion
waveform, range of values, sensitivity to substantial variation in
the waveform, usefulness in combination with other statistics
and sensitivity and speciﬁcity in predicting hypoglycemic events.
CONCLUSIONS: Several signal processing ﬁlters appear to be
effective for extraction of information from CGM series, and
some of these appear promising as a basis for new indices of
glycemic control and for classiﬁcation of patients and effects of
medications such as rapidly acting insulin analogs that blunt the
post-prandial excursions.
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OBJECTIVE: Studies have indicated that independent pharma-
cies outperform chain pharmacies in one-on-one personal atten-
tion and quality of patient counseling. However, there are no
studies examining whether these beneﬁts translate into outcomes
